A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Most portable air conditioners suck – but there's an easy fix
2
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
3
We've found a mysterious substance on Titan and Pluto
4
A quantum state that lasts forever may finally be within our grasp
5
Faecal transplant makes the brains of old mice act young again
6
Fully autonomous drones have killed human soldiers for the first time
7
Has the answer to life's origins been hiding in our cells all along?
8
100-year-old assumption about the universe may soon be overturned
9
Cervical cancer deaths have plummeted thanks to HPV vaccine
10
Why you need to future-proof your brain in middle age and how to start
